M. N. Ballinger and T. J. Standiford, Postinfluenza bacterial pneumonia: host defenses gone awry, J Interferon Cytokine Res, vol.30, pp.643-652, 2010.
DOI : 10.1089/jir.2010.0049
URL : http://europepmc.org/articles/pmc4367524?pdf=render

J. Hament, J. Kimpen, A. Fleer, and T. Wolfs, Respiratory viral infection predisposing for bacterial disease: a concise review, FEMS Immunol Med Microbiol, vol.26, pp.189-195, 1999.
DOI : 10.1016/s0928-8244(99)00159-5
URL : https://academic.oup.com/femspd/article-pdf/26/3-4/189/19164094/26-3-4-189.pdf

B. Henriques-normark and S. Normark, Commensal pathogens, with a focus on Streptococcus pneumoniae, and interactions with the human host, Exp Cell Res, vol.316, pp.1408-1414, 2010.

C. Joseph, Y. Togawa, and N. Shindo, Bacterial and viral infections associated with influenza, Influenza Other Respir Viruses, vol.7, pp.105-113, 2013.

J. C. Kash and J. K. Taubenberger, The role of viral, host, and secondary bacterial factors in influenza pathogenesis, Am J Pathol, vol.185, pp.1528-1536, 2015.

R. E. Mendes, A. J. Costello, M. R. Jacobs, D. Biek, I. A. Critchley et al., Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine, Diagn Microbiol Infect Dis, vol.80, pp.19-25, 2014.

K. E. Lamb, S. Flasche, M. Diggle, D. Inverarity, D. Greenhalgh et al., Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, Vaccine, vol.32, pp.4356-4363, 1999.
URL : https://hal.archives-ouvertes.fr/hal-01262504

Z. Shriver, J. M. Trevejo, and R. Sasisekharan, Antibody-based strategies to prevent and treat influenza, Front Immunol, vol.6, p.315, 2015.
DOI : 10.3389/fimmu.2015.00315
URL : https://www.frontiersin.org/articles/10.3389/fimmu.2015.00315/pdf

L. A. Jackson and E. N. Janoff, Pneumococcal vaccination of elderly adults: new paradigms for protection, Clin Infect Dis, vol.47, pp.1328-1338, 2008.
DOI : 10.1086/592691
URL : https://academic.oup.com/cid/article-pdf/47/10/1328/1230548/47-10-1328.pdf

A. Tessmer, T. Welte, P. Martus, M. Schnoor, R. Marre et al., Impact of intravenous ?-lactam/macrolide versus ?-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia, J Antimicrob Chemother, vol.63, pp.1025-1033, 2009.

A. Rodriguez, T. Lisboa, S. Blot, I. Martin-loeches, J. Solé-violan et al., Mortality in ICU patients with bacterial communityacquired pneumonia: when antibiotics are not enough, Intensive Care Med, vol.35, pp.430-438, 2009.

. García-suárez-mdm, M. D. Cima-cabal, N. Flórez, P. García, R. Cernudacernuda et al., Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin, Infect Immun, vol.72, pp.4534-4540, 2004.

C. J. Orihuela, G. Gao, K. P. Francis, J. Yu, and E. I. Tuomanen, Tissue-specific contributions of pneumococcal virulence factors to pathogenesis, J Infect Dis, vol.190, pp.1661-1669, 2004.

J. H. Lim, B. Stirling, J. Derry, T. Koga, H. Jono et al., Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections, Immunity, vol.27, pp.349-360, 2007.

W. C. Albrich, D. L. Monnet, and S. Harbarth, Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes, Emerg Infect Dis, vol.10, pp.514-517, 2004.

S. H. Kim, J. Song, D. R. Chung, V. Thamlikitkul, Y. Yang et al., Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study, Antimicrob Agents Chemother, vol.56, pp.1418-1426, 2012.

E. L. Nuermberger and W. R. Bishai, Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?, Clin Infect Dis, vol.38, pp.363-371, 2004.

B. M. Gray and H. C. Dillon, Clinical and epidemiologic studies of pneumococcal infection in children, Pediatr Infect Dis, vol.5, pp.201-207, 1986.

C. J. Clancy, A. C. Kalil, V. G. Fowler, E. Ghedin, J. K. Kolls et al., Emerging and resistant infections, Ann Am Thorac Soc, vol.11, 2014.

J. E. Cornick and S. D. Bentley, Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides, Microbes Infect, vol.14, pp.573-583, 2012.

G. Barcenas-morales, P. Jandus, and R. Döffinger, Anticytokine autoantibodies in infection and inflammation: an update, Curr Opin Allergy Clin Immunol, vol.16, pp.523-529, 2016.

J. Ricard, New therapies for pneumonia, Curr Opin Pulm Med, vol.18, pp.181-186, 2012.

Y. L. Xiao, J. C. Kash, S. B. Beres, Z. M. Sheng, J. M. Musser et al., High-throughput RNA sequencing of a formalin-fixed, paraffinembedded autopsy lung tissue sample from the 1918 influenza pandemic, J Pathol, vol.229, pp.535-545, 2013.

L. Li, H. C. Chong, S. Y. Ng, K. W. Kwok, Z. Teo et al., Angiopoietin-like 4 increases pulmonary tissue leakiness and damage during influenza pneumonia, Cell Rep, vol.10, pp.654-663, 2015.

J. Song, R. Dagan, K. P. Klugman, and B. Fritzell, The relationship between pneumococcal serotypes and antibiotic resistance, Vaccine, vol.30, pp.2728-2737, 2012.

J. Song, J. Ko, K. S. Kim, N. Y. Son, J. S. Chang et al., High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study), Antimicrob Agents Chemother, vol.48, pp.2101-2107, 2004.

I. Julkunen, K. Mele, M. Nyqvist, J. Pirhonen, and T. Sareneva, Inflammatory responses in influenza A virus infection, Vaccine, vol.19, pp.32-37, 2001.

J. Mcgill, J. W. Heusel, and K. L. Legge, Innate immune control and regulation of influenza virus infections, J Leukoc Biol, vol.86, pp.803-812, 2009.

J. E. Kohlmeier and D. L. Woodland, Immunity to respiratory viruses, Annu Rev Immunol, vol.27, pp.61-82, 2009.

I. Julkunen, T. Sareneva, J. Pirhonen, R. T. Melén, K. Matikainen et al., Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression, Cytokine Growth Factor Rev, vol.12, pp.26-31, 2001.

J. Nicholls and M. Peiris, Good ACE, bad ACE do battle in lung injury, SARS, Nat Med, vol.11, pp.821-822, 2005.

A. C. Monsalvo, J. P. Batalle, M. F. Lopez, J. C. Krause, J. Klemenc et al., Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes, Nat Med, vol.17, pp.195-199, 2011.
DOI : 10.1038/nm.2262
URL : http://europepmc.org/articles/pmc3034774?pdf=render

R. J. Snelgrove, L. Edwards, A. J. Rae, and T. Hussell, An absence of reactive oxygen species improves the resolution of lung influenza infection, Eur J Immunol, vol.36, pp.1364-1373, 2006.

D. Kobasa, S. M. Jones, K. Shinya, J. C. Kash, J. Copps et al., Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus, Nature, vol.445, pp.319-323, 2007.

J. P. Buchweitz, J. R. Harkema, and N. E. Kaminski, Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice, Toxicol Pathol, vol.35, pp.424-435, 2007.

C. Small, S. Mccormick, N. Gill, K. Kugathasan, M. Santosuosso et al., NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung, J Immunol, vol.180, pp.5558-5568, 2008.

C. Small, C. R. Shaler, S. Mccormick, M. Jeyanathan, D. Damjanovic et al., Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung, J Immunol, vol.184, pp.2048-2056, 2010.

K. L. Hartshorn, New look at an old problem: bacterial superinfection after influenza, Am J Pathol, vol.176, pp.536-539, 2010.

N. Uchide and H. Toyoda, Antioxidant therapy as a potential approach to severe influenza-associated complications, Molecules, vol.16, pp.2032-2052, 2011.
DOI : 10.3390/molecules16032032
URL : http://www.mdpi.com/1420-3049/16/3/2032/pdf

J. R. Aldridge, C. E. Moseley, D. A. Boltz, N. J. Negovetich, C. Reynolds et al., TNF/iNOSproducing dendritic cells are the necessary evil of lethal influenza virus infection, Proc Natl Acad Sci U S A, vol.106, pp.5306-5311, 2009.

A. N. Moorthy, P. Rai, H. Jiao, S. Wang, K. B. Tan et al., Capsules of virulent pneumococcal serotypes enhance formation of neutrophil extracellular traps during in vivo pathogenesis of pneumonia, Oncotarget, vol.7, pp.19327-19340, 2016.

A. Narayana-moorthy, T. Narasaraju, P. Rai, R. Perumalsamy, K. B. Tan et al., In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection, Front Immunol, vol.4, p.56, 2013.

M. Jerebtsova and S. Nekhai, Therapeutics for postexposure treatment of Ebola virus infection, Future Virol, vol.10, pp.221-232, 2015.

J. Murray, S. Saxena, and M. Sharland, Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals, Arch Dis Child, vol.99, pp.469-473, 2014.
DOI : 10.1136/archdischild-2013-303764

M. Pelegrin, M. Naranjo-gomez, and M. Piechaczyk, Antiviral monoclonal antibodies: can they be more than simple neutralizing agents?, Trends Microbiol, vol.23, pp.653-665, 2015.
DOI : 10.1016/j.tim.2015.07.005

T. J. Mitchell, F. Mendez, J. C. Paton, P. W. Andrew, and G. J. Boulnois, Comparison of pneumolysin genes and proteins from Streptococcus pneumoniae types 1 and 2, Nucleic Acids Res, vol.18, p.4010, 1990.

L. Li, V. Chow, and N. S. Tan, Targeting vascular leakage in lung inflammation, Oncotarget, vol.6, pp.19338-19339, 2015.

L. Guo, S. Li, Y. Zhao, P. Qian, J. F. Qian et al., Silencing angiopoietin-like protein 4 (ANGPTL4) protects against lipopolysaccharideinduced acute lung injury via regulating SIRT1/NF-kB pathway, J Cell Physiol, vol.230, pp.2390-2402, 2015.
DOI : 10.1002/jcp.24969

M. G. Sugiyama, S. M. Armstrong, C. Wang, D. Hwang, H. Leong-poi et al., The Tie2-agonist Vasculotide rescues mice from influenza virus infection, Sci Rep, vol.5, p.11030, 2015.

Y. Ito, Y. Oike, K. Yasunaga, K. Hamada, K. Miyata et al., Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4, Cancer Res, vol.63, pp.6651-6657, 2003.

R. Huang, Z. Teo, H. C. Chong, P. Zhu, M. J. Tan et al., ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters, Blood, vol.118, pp.3990-4002, 2011.

Y. Y. Goh, M. Pal, H. C. Chong, P. Zhu, M. J. Tan et al., Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing, J Biol Chem, vol.285, pp.32999-33009, 2010.

P. Zhu, M. J. Tan, R. L. Huang, C. K. Tan, H. C. Chong et al., Angiopoietinlike 4 protein elevates the prosurvival intracellular O 2 ? :H 2 O 2 ratio and confers anoikis resistance to tumors, Cancer Cell, vol.19, pp.401-415, 2011.

C. Quast, E. Pruesse, P. Yilmaz, J. Gerken, T. Schweer et al., The SILVA ribosomal RNA gene database project: improved data processing and web-based tools, Nucleic Acids Res, vol.41, pp.590-596, 2013.

V. A. Kempf, K. Trebesius, and I. B. Autenrieth, Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures, J Clin Microbiol, vol.38, pp.830-838, 2000.

C. Lam, M. J. Tan, S. H. Tan, M. Tang, P. Cheung et al., TAK1 regulates SCF expression to modulate PKB? activity that protects keratinocytes from ROS-induced apoptosis, Cell Death Differ, vol.18, pp.1120-1129, 2011.

C. Lam, C. Tan, Z. Teo, C. Y. Tay, T. Phua et al., Loss of TAK1 increases cell traction force in a ROSdependent manner to drive epithelial-mesenchymal transition of cancer cells, Cell Death Dis, vol.4, 2013.

H. C. Chong, J. Chan, C. Q. Goh, N. V. Gounko, B. Luo et al., Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice, Mol Ther, vol.22, pp.1593-1604, 2014.

M. I. Love, W. Huber, and S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, vol.15, p.550, 2014.

G. R. Bernard, A. Artigas, K. L. Brigham, J. Carlet, K. Falke et al., The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination, Am J Respir Crit Care Med, vol.149, pp.818-824, 1994.

N. Sakamoto, T. Kakugawa, A. Hara, S. Nakashima, H. Yura et al., Association of elevated ?-defensin levels with interstitial pneumonia in patients with systemic sclerosis, Respir Res, vol.16, p.148, 2015.